Skip to main content

Drug Stocks Ignoring Obamacare

The healthcare industry is thriving despite Obamacare's rocky rollout, says Terry Hisey, Vice Chairman Healthcare Life Sciences at Deloitte.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Scroll to Continue

TheStreet Recommends